SCHEMBL22270835

SCHEMBL22270835

C=C(Cc1ccc(CCC)cc1)Nc1ccc(-c2nccnc2-c2ccccc2CC)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDR P35968 1/20 0.42
▸ WNT3A P56704 1/20 0.35
▸ ABCG2 Q9UNQ0 1/20 0.35
▸ TRPV1 Q8NER1 3/20 0.35
▸ CCNE2 O96020 1/20 0.35
▸ CDK4 P11802 1/20 0.35
▸ CCND1 P24385 1/20 0.35
▸ CCNE1 P24864 1/20 0.35
▸ CDK2 P24941 1/20 0.35
▸ RAB9A P51151 3/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ NPC1 O15118 2/20 0.34
▸ NFKB1 P19838 1/20 0.34
▸ NFKB2 Q00653 1/20 0.34
▸ RELA Q04206 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ NLRP3 Q96P20 1/20 0.34
▸ MAPT P10636 2/20 0.34
▸ ADRB2 P07550 2/20 0.34
▸ PDE10A Q9Y233 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18483428 0.85 KDR (0.40) KDRWNT3ATRPV1CCNE2CDK4
SCHEMBL22271057 0.79 TRPV1 (0.43) TRPV1RAB9AALDH1A1NPC1SMN1; SMN2
SCHEMBL22270626 0.79 KDR (0.35) KDRWNT3ATRPV1RAB9ANPC1
SCHEMBL22271081 0.76 RORC (0.44) WNT3ATRPV1
SCHEMBL29470979 0.75 NPSR1 (0.42) RAB9AALDH1A1NPC1SMN1; SMN2LMNA
SCHEMBL26382379 0.75 WNT3A (0.47) WNT3ATRPV1RAB9ANPC1SMN1; SMN2
SCHEMBL18483362 0.74 ALDH1A1 (0.38) TRPV1CDK2ALDH1A1PDE10A
SCHEMBL22271025 0.74 FFAR1 (0.37) ADRB2ADRB1ADRB3
SCHEMBL21133947 0.74 RORC (0.44) WNT3ATRPV1NPC1LMNA
SCHEMBL29471013 0.74 RORC (0.46) WNT3ATRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3686187-A1 PROCESS FOR THE PREPARATION OF ROR GAMMA MODULATORS Glenmark Pharmaceuticals S.A. (CH) 2020-07-29 — — EP disclosed
Send feedback